Dr. Martens (LON:DOCS) Trading Up 25.8% – Should You Buy?

Dr. Martens plc (LON:DOCS)’s share price rose 25.8% during trading on Thursday . The company traded as high as GBX 76 ($1.03) and last traded at GBX 75.40 ($1.02). Approximately 8,364,149 shares traded hands during mid-day trading, an increase of 271% from the average daily volume of 2,253,765 shares. The stock had previously closed at GBX 59.95 ($0.81).

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada reduced their price objective on Dr. Martens from GBX 7,000 ($94.70) to GBX 6,000 ($81.17) and set a “sector perform” rating for the company in a research note on Monday, May 19th.

Dr. Martens Stock Performance

The firm has a market cap of £795.54 million, a PE ratio of 11.62, a PEG ratio of 6.40 and a beta of 0.11. The company has a debt-to-equity ratio of 127.27, a quick ratio of 1.13 and a current ratio of 2.85. The firm’s 50 day moving average price is GBX 55.34 and its two-hundred day moving average price is GBX 62.80.

Dr. Martens (LON:DOCS) last released its quarterly earnings results on Thursday, June 5th. The company reported GBX 2.40 ($0.03) earnings per share for the quarter. Dr. Martens had a return on equity of 18.91% and a net margin of 7.89%. On average, research analysts forecast that Dr. Martens plc will post 2.5809394 earnings per share for the current year.

Dr. Martens Cuts Dividend

The firm also recently declared a dividend, which was paid on Tuesday, April 8th. Shareholders of record on Thursday, March 6th were given a GBX 0.85 ($0.01) dividend. The ex-dividend date of this dividend was Thursday, March 6th. This represents a yield of 1.47%. Dr. Martens’s dividend payout ratio is presently 42.53%.

Insider Activity at Dr. Martens

In other Dr. Martens news, insider Giles Wilson purchased 32,640 shares of Dr. Martens stock in a transaction that occurred on Tuesday, March 25th. The stock was purchased at an average price of GBX 54 ($0.73) per share, for a total transaction of £17,625.60 ($23,844.16). Over the last three months, insiders purchased 33,206 shares of company stock worth $1,792,771. Company insiders own 4.36% of the company’s stock.

Dr. Martens Company Profile

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.

The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.